Loading Events

« All Events

  • This event has passed.

The Current and Future Stat…

September 16, 2021 @ 4:00 pm - 5:00 pm

Program Description

This advanced program focuses on how fundamental features of the healthcare landscape are changing.  The topics discussed go into detail on:
  • Controlling product access​
  • Stakeholders in product distribution​​
  • Carving out financial risk
  • The growing role of IDNs​

Program Structure

Upon registration, you will be assigned a set of e-learning courses to complete prior to the live webinar. These courses will detail key topics impacting market access today: ​
  • The IDN Business Model​
  • Marketplace Pressures​​
  • The Evolving Payer Business Model
The live discussion pulls through concepts learned and demonstrates real-world examples. Come prepared to think constructively about your business environment as it relates to the topics discussed.​

What to Expect​

Once you purchase a MAP Program, you will receive 3 emails from ProFusion MAP:​
  • Welcome! Learning Awaits​
    • This email will provide you with account information for access to the MAP Program you registered for​
  • Register for…
    • This email will list all available live webinar sessions for the MAP Program you purchased​
    • Sessions are closed to registration after the 10-person max is reached. Sign up early!​
  • You’re enrolled in…​
    • This email will direct you to the MAP Program with all e-learning courses to complete before your live session​
    • These courses are only available for 90 days after your purchase date. You are encouraged to complete all courses prior to the live session​
​Tip: You can save the ProFusion MAP LMS to your bookmark for quick access!​ If you have any questions, contact ProFusion MAP Support at +1 877-369-2580​

Calendar of Events

M Mon

T Tue

W Wed

T Thu

F Fri

S Sat

S Sun

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

0 events,

Manufacturers Restricting 340B Sales to Contract Pharmacies

  • Abbvie
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • UCB
  • United Therapeutics
  • and more…